X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.（XFOR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · XFOR · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
1
近12个月
买卖比
1.00
Buy/Sell (by trades)
整体情绪
X4 Pharmaceuticals, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
XFOR 季度内部人买卖趋势
XFOR 内幕交易卖出 · XFOR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · XFOR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
XFOR 高管卖出股份 · XFOR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 12, 2026 | KIRSKE DAVID CFO | Sale | 16,961 | $73K | Form 4 |
| Oct 23, 2025 | Craig Adam R Executive Chairman · Director | Purchase | 86,206 | $250K | Form 4 |
| Aug 14, 2025 | Volpone John President | Award | 289,881 | — | Form 4 |
| Aug 14, 2025 | Craig Adam R Executive Chairman · Director | Award | 289,881 | — | Form 4 |
| Aug 14, 2025 | KIRSKE DAVID CFO | Award | 193,254 | — | Form 4 |
| May 20, 2025 | Thoren Natasha Fay Chief Legal Officer | Award | 3,333 | — | Form 4 |
| Jun 9, 2025 | Stewart Murray Director | Award | 1,500 | — | Form 4 |
| Jun 9, 2025 | de Craecker Francoise Director | Award | 1,500 | — | Form 4 |
| Jun 9, 2025 | Bridger Gary Director | Award | 1,500 | — | Form 4 |
| Jun 9, 2025 | Woods Keith Director | Award | 1,500 | — | Form 4 |
| Jun 9, 2025 | MCGIRR DAVID W J Director | Award | 1,500 | — | Form 4 |
| Jun 9, 2025 | WYZGA MICHAEL S Director | Award | 1,500 | — | Form 4 |
| May 16, 2025 | Baldry Mark Chief Commercial Officer | Purchase | 1,032 | $3K | Form 4 |
| Feb 12, 2025 | Arbet-Engels Christophe Chief Medical Officer | Award | 850,000 | — | Form 4 |
| Feb 12, 2025 | Mostafa Adam S. CFO | Award | 850,000 | — | Form 4 |
| Feb 12, 2025 | Ragan Paula President and CEO · Director | Award | 2,250,000 | — | Form 4 |
| Feb 12, 2025 | Baldry Mark Chief Commercial Officer | Award | 600,000 | — | Form 4 |
| Nov 15, 2024 | Baldry Mark Chief Commercial Officer | Purchase | 13,404 | $5K | Form 4 |
| May 17, 2024 | Baldry Mark Chief Commercial Officer | Purchase | 21,646 | $15K | Form 4 |
| Feb 12, 2025 | DiBiase Mary COO | Award | 650,000 | — | Form 4 |
| Jan 23, 2025 | Ragan Paula President and CEO · Director | Award | 169,940 | — | Form 4 |
| Jan 24, 2025 | Ragan Paula President and CEO · Director | Sale | 76,473 | $35K | Form 4 |
| Jan 23, 2025 | Mostafa Adam S. CFO | Award | 74,773 | — | Form 4 |
| Jan 24, 2025 | Mostafa Adam S. CFO | Sale | 74,773 | $34K | Form 4 |
| Jan 23, 2025 | Baldry Mark Chief Commercial Officer | Award | 74,773 | — | Form 4 |
Craig Adam R
Executive Chairman · Director
日期
Oct 23
股数
86,206
均价
$2.90
总金额
$250K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 XFOR 内幕交易
XFOR 内幕交易
X4 Pharmaceuticals, Inc.（XFOR）内幕交易数据来源于公司内部人（包括KIRSKE DAVID (CFO), Craig Adam R (Executive Chairman · Director), Volpone John (President)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。XFOR内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看X4 Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
XFOR 内幕交易 · 5个问题X4 Pharmaceuticals, Inc.（XFOR）的内部人包括高管和董事，如KIRSKE DAVID (CFO), Craig Adam R (Executive Chairman · Director), Volpone John (President)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026